Most not too long ago, it's been identified that conolidine and the above mentioned derivatives act on the atypical chemokine receptor 3 (ACKR3. Expressed in identical places as classical opioid receptors, it binds to the big range of endogenous opioids. Not like most opioid receptors, this receptor acts for a scavenger and doesn't activate a secon